RAB7 protects against ischemic heart failure via promoting non-canonical TUFM mitophagy pathway
Theranostics · 2025
DOI: 10.7150/thno.104124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Yuling Sun und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respira…. Hauptthemen laut MEDLINE: Mitophagy, rab GTP-Binding Proteins, Heart Failure, Myocardial Ischemia. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Rationale
Cardiomyocyte apoptosis critically contributes to ischemic heart failure (IHF) progression. While the endosome-lysosome system governs cellular homeostasis, the functional significance of its master regulator RAB7 in cardiac pathophysiology remains unexplored.
Methods
Using myocardial infarction (MI) models via left anterior descending coronary artery ligation in cardiomyocyte-specific RAB7 knockout mice and adeno-associated virus-mediated RAB7 overexpression models, we assessed cardiac function and adverse remodeling through echocardiography and pathophysiological assessment. Mitophagy flux was quantified using mt-Keima mice and confocal imaging. Molecular mechanisms were dissected through immunoprecipitation coupled with mass spectrometry (IP-MS) analysis and molecular experiment validation.
Results
RAB7 expression decreased in ischemic myocardium. Cardiomyocyte-specific RAB7 ablation exacerbated while RAB7 overexpression attenuated post-MI cardiac dysfunction and maladaptive remodeling. RAB7 enhanced mitophagic clearance of damaged mitochondria, reducing cardiomyocyte apoptosis under ischemic stress both in vitro and in vivo. Mechanistically, TUFM, a mitochondrial translation elongation factor, was identified as a novel effector of RAB7. RAB7 facilitated the recruitment of TUFM and LC3 to damaged mitochondria, thereby enhancing mitophagy. TUFM knockdown significantly diminished the protective effects of RAB7 on mitophagy and cardiomyocyte survival. Finally, administration of ML-098, a chemical RAB7 activator, promoted mitophagy and mitigated IHF progression in mice.
Conclusion
We identify RAB7 as a novel coordinator of cardioprotective mitophagy through TUFM-mediated machinery assembly. The RAB7-TUFM axis represents a therapeutic target for IHF that warrants further clinical evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical Uni…
- Department of Thoracic Surgery, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou 510260, China.
- Department of Cardiology, Guangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou 510260, China.
- Institute for Cardiovascular Science and Department of Cardiovascular Surgery of First Affiliated Hospital, Suzhou Medical College, Soochow University, Suzhou, Jiangsu 215031, China.
Zitieren
APA
Sun, Y., Wang, W., Li, M., Guan, W., Gao, Z., Wang, L., Lou, G., Shen, A., Wu, J., Yu, X., Wang, P., & Wu, X. (2025). RAB7 protects against ischemic heart failure via promoting non-canonical TUFM mitophagy pathway. Theranostics. https://doi.org/10.7150/thno.104124
Vancouver
Sun Y, Wang W, Li M, Guan W, Gao Z, Wang L, et al. RAB7 protects against ischemic heart failure via promoting non-canonical TUFM mitophagy pathway. Theranostics. 2025. doi:10.7150/thno.104124
BibTeX
@article{Sun2025,
author = {Sun, Yuling and Wang, Wei and Li, Mingyan and Guan, Wen and Gao, Zhimin and Wang, Luping and Lou, Guanlan and Shen, Ao and Wu, Jiangbin and Yu, Xiyong and Wang, Panxia and Wu, Xiaoqian},
title = {RAB7 protects against ischemic heart failure via promoting non-canonical TUFM mitophagy pathway},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.104124}
}
EUVIMED